Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Article Type
- Comparative Study1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Med J Aust1
Search Results
Sort by
- BookMiranda A. Farage, Kenneth W. Miller, Nancy Fugate Woods, Howard I. Maibach, editors.Summary: An era of global population aging is upon us. By 2030, one in eight people will be over age 65. Since women generally live longer than men, the health and welfare of postmenopausal women will become a significant public health concern. This book offers a comprehensive review of the life changes associated with menopause, both at the dermatological and physiological level (e.g., hormonal, immunological) and at the subcellular level. It critically examines the dermatological, biological, and clinical challenges to postmenopausal health and well-being and the current and emerging therapeutic interventions. The authors advocate a holistic approach, emphasizing the need to view the menopause as a life transition with various facets rather than as a series of distinct medical conditions to be managed. Our goal is to offer a comprehensive resource to the researchers, clinicians, physicians, and helping professions whose mission is to promote the health and well-being of women around the world.
Contents:
What is Menopause?
Skin and Menopause
Effect of Supplementations and Vitamins on Menopause
Hormonal Change and Therapy
Menopause and Genital
Menopause and Autoimmune Disease
Hotflahes
Other Therapy for Menopause
Sexual Decline
Menopause Tests
Menopause and Sleep
Menopause and Mental Effects
Menopause and Quality of Life
Menopause and cosmetic procedures. - ArticleHoward MA, Whitworth JA, Hendrix LE, Thomas KB, Firkin BG.Med J Aust. 1979 Mar 10;1(5):148-51.Factor VIII procoagulant activity (VIII-C), related antigen (VIII-AG), and von Willebrand factor (VIII-vWf) were measured in 38 patients with chronic renal failure (CRF), in 19 patients with normal renal function from a general medical ward, and in 17 normal subjects. Wide variation in the levels of factor VIII (FVIII) functions were found in the group of CRF patients. There was no correlation between the levels of the three individual activities of FVIII in renal disease. The levels of the three functions were elevated in the patient controls and no significant differences were found between the two groups of patients, although both groups were significantly different from the normal subjects. Increased electrophoretic mobility (EM) was detected in 22 of the 38 patients with CRF (58%) compared to seven of the 19 patients controls (37%). These studies suggest caution in interpretation of changes in FVIII status in patients with other clinical disorders, such as liver disease.